In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.

In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.

Bibliographic Details
Main Authors:	Kersemans, V, Kersemans, K, Cornelissen, B, Achten, E, Dierckx, R, Mertens, J, Slegers, G
Format:	Conference item
Published:	2004

Similar Items

In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
by: Kersemans, V, et al.
Published: (2004)

Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
by: Kersemans, V, et al.
Published: (2004)

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
by: Kersemans, V, et al.
Published: (2005)

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
by: Kersemans, V, et al.
Published: (2005)

123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
by: Kersemans, V, et al.
Published: (2006)

Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
by: Kersemans, V, et al.
Published: (2006)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
by: Cornelissen, B, et al.
Published: (2004)

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
by: Kersemans, V, et al.
Published: (2006)

Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma.
by: Peremans, K, et al.
Published: (2007)

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice.
by: Cornelissen, B, et al.
Published: (2005)

A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
by: Cornelissen, B, et al.
Published: (2003)

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
by: Oltenfreiter, R, et al.
Published: (2004)

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
by: Cornelissen, B, et al.
Published: (2004)

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.
by: Cornelissen, B, et al.
Published: (2005)

Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy
by: Kersemans, V, et al.
Published: (2010)

In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
by: Cornelissen, B, et al.
Published: (2005)

Cell penetrating peptides for in vivo molecular imaging applications.
by: Kersemans, V, et al.
Published: (2008)

Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
by: Cornelissen, B, et al.
Published: (2013)

Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one, a potential dopamine D4 ligand for SPECT studies
by: Staelens, L, et al.
Published: (2005)

Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status.
by: Cornelissen, B, et al.
Published: (2004)

A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
by: Veal, M, et al.
Published: (2021)

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
by: Song, L, et al.
Published: (2016)

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
by: Cornelissen, B, et al.
Published: (2005)

Immuno-imaging of ICAM-1 in tumours by SPECT
by: Mosley, M, et al.
Published: (2020)

Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
by: Mosley, M, et al.
Published: (2015)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2019)

Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity.
by: Maw Pin Tan, et al.
Published: (2015-01-01)

Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.
by: Kersemans, V, et al.
Published: (2011)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
by: Baguna-Torres, J, et al.
Published: (2020)

Diagnostic Efficacy of <sup>123</sup>Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies
by: Johannes M. Hagen, et al.
Published: (2024-12-01)

A carbon-fiber sheet resistor for MR-, CT-, SPECT-, and PET-compatible temperature maintenance in small animals
by: Kersemans, V, et al.
Published: (2019)

RADIONUCLIDE SCANNING WITH I-123 IN GRAVES DISEASE
by: Putu Diah Vedayanti, et al.
Published: (2014-01-01)

Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2018)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
by: McLarty, K, et al.
Published: (2009)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
by: Kaltsas, G, et al.
Published: (1998)

Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.
by: Cornelissen, B
Published: (2014)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
by: McLarty, K, et al.
Published: (2009)

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
by: Cornelissen, B, et al.
Published: (2006)

In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
by: Burvenich, I, et al.
Published: (2005)

CT-based attenuation correction in I-123-ioflupane SPECT.
by: Catharina Lange, et al.
Published: (2014-01-01)